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The retinoblastoma protein (Rb) as an anti-apoptotic
factor: expression of Rb is required for the anti-
apoptotic function of BAG-1 protein in colorectal
tumour cells
TJ Collard1, B Urban1, H Patsos1, A Hague2, P Townsend3, C Paraskeva1 and AC Williams*,1
Although the retinoblastoma-susceptibility gene RB1 is inactivated in a wide range of human tumours, in colorectal cancer, the
retinoblastoma protein (Rb) function is often preserved and the RB locus even amplified. Importantly, we have previously shown
that Rb interacts with the anti-apoptotic Bcl-2 associated athanogene 1 (BAG-1) protein, which is highly expressed in colorectal
carcinogenesis. Here we show for the first time that Rb expression is critical for BAG-1 anti-apoptotic activity in colorectal
tumour cells. We demonstrate that Rb expression not only increases the nuclear localisation of the anti-apoptotic BAG-1 protein,
but that expression of Rb is required for inhibition of apoptosis by BAG-1 both in a c-irradiated Saos-2 osteosarcoma cell line and
colorectal adenoma and carcinoma cell lines. Further, consistent with the fact that nuclear BAG-1 has previously been shown to
promote cell survival through increasing nuclear factor (NF)-jB activity, we demonstrate that the ability of BAG-1 to promote
NF-jB activity is significantly inhibited by repression of Rb expression. Taken together, data presented suggest a novel function
for the Rb, promoting cell survival through regulating the function of BAG-1. As BAG-1 is highly expressed in the majority of
colorectal tumours, targeting the Rb–BAG-1 complex to promote apoptosis has exciting potential for future therapeutic
development.
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Evasion of apoptosis is a hallmark of cancer and contributes
both to the development of the tumour and the refractory
nature of tumours to treatment.1 Understanding the molecular
basis of resistance to apoptosis in colorectal cancer cells is
essential if we are to identify novel targets for the prevention
and treatment of colorectal cancer.
Retinoblastoma protein (Rb) is a well-established tumour-
suppressor protein, regulating the transition of the restriction
point in the cell cycle. Rb activity is also thought to be of
importance in cell-fate determination; Rb is known to interact
with lineage-specific transcription factors, including PU.1 and
Id2 (erythroid development), Runx2 (bone development),
MyoD (muscle) and Pdx1 (pancreatic development).2,3
Further, loss of Rb function has recently shown to be sufficient
to induce uncontrolled proliferation in stem cell populations.4–6
However, apparently contradicting its role as a classical
tumour-suppressor protein, colorectal cancer cells retain
expression of the retinoblastoma tumour-suppressor protein
(Rb); they express high levels of Rb compared with adjacent
normal tissue, and loss or mutations of the RB gene are
rare.7,8 Furthermore, a study by Ali et al.9 first revealed that
colorectal tumours express entirely normal transcripts of
retinoblastoma gene.9 It is now recognised that Rb function is
nearly always preserved and the RB locus sometimes even
amplified in colorectal cancer.10,11
Much of the work on the function of Rb in colorectal
carcinogenesis has centred on its ability to inhibit the E2F-
dependent transcription. Of note, a recent study attributed the
retention of Rb function in colorectal cancer cells to its ability to
repress E2F-1-dependent inactivation of b-catenin signal-
ling.10,12 However, it is also well established that expression of
Rb can promote cell survival through repression of E2F-driven
apoptosis.13 In fact, Rb was first recognised as anti-apoptotic
in the RB1-knockout mice, which were found to be nonviable
due to extensive apoptosis in neuronal and haematopoietic
cells.14–16 Further, Rb-deficient cells were reported to bemore
susceptible to apoptosis than cells with fully functional Rb,17,18
and Rb expression inhibited cell death induced by DNA-
damaging agents.19,20 Although many studies have attributed
the anti-apoptotic activity of Rb to repression of E2F-1
function, more recently Rb has also been reported to co-
operate with E2F to activate pro-apoptotic genes in response
to genotoxic stress.21 Current evidence therefore suggests
that the Rb status could be critical in influencing the sensitivity
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of colorectal tumour cells to apoptosis. In this context, it is of
interest that Rb has also been shown to interact with other
proteins involved in regulating apoptosis, including the anti-
apoptotic Bcl-2 associated athanogene 1 (BAG-1) protein,
highly expressed in colorectal tumour cells.22,23
BAG-1 was discovered as a novel regulator of apoptosis
through its ability to bind to Bcl-2.24 Studies have since shown
BAG-1 to be a multifunctional protein involved in a number of
key cellular processes including proliferation, differentiation,
cell cycle, transcription and apoptosis.25,26 Characterised by
the BAG domain, BAG-1 is a member of a family of related
proteins, of which there are at least six in humans.27 The
human BAG-1 gene encodes three BAG-1 isoforms, BAG-1S
(p36), BAG-1M (p46) and BAG-1L (p50), generated via
alternate translation mechanisms from a single mRNA.28,29
The different BAG-1 isoforms have distinct subcellular
localisations within the cell. Early studies reported that the
smaller of the isoforms BAG-1S is preferentially located in the
cytoplasm, the BAG-1M isoform is detected in both the
nuclear and cytoplasmic compartments, and the BAG-1L
isoform is located in the nucleus.28,30–32 The difference in the
subcellular localisation of the BAG-1 isoforms is thought to be
conferred at least in part by a nuclear localisation signal
present in the N-terminus of the BAG-1L isoform, but absent
in the BAG-1S and truncated in the BAG-1M isoform.28,31–33
Of note, contrary to the published literature, the localisation of
the smaller BAG-1 isoforms in colorectal tumour cells
appears distinct from other tissues, with the BAG-1M isoform
being predominantly nuclear and the BAG- 1S isoform
exhibiting nuclear as well as cytoplasmic localisation.34 The
cumulative result is a predominant nuclear localisation of
endogenous BAG-1 protein in colorectal epithelial cells
(important for the transcriptional function of the protein26);
previously associated with poor prognosis in colorectal
cancer.35
BAG-1 is an important pro-survival protein in tumorigen-
esis; it has been shown to be overexpressed in a number of
cancers29 and to inhibit apoptosis in a variety of different cell
types.25 Overexpressed in colorectal adenoma and carci-
noma tissue,23 nuclear BAG-1 has been reported to correlate
with poor prognosis35 and promote tumour cell survival.34
Interestingly, BAG-1 function has been linked to promoting the
activity of the nuclear factor (NF)-kB pro-survival signalling
pathway,23 and was found to act as a co-regulator of gene
expression through interaction with the p50-p50 NF-kB
complexes,36 suggesting a potentially important role for the
BAG-1 NF-kB complex in colorectal carcinogenesis. Further-
more, recently it has been suggested that BAG-1 expression
is the critical determinant in preventing c-MYC-induced
apoptosis,37 further emphasising the potential importance of
BAG-1 function in colorectal carcinogenesis.
As we have previously established that the anti-apoptotic
BAG-1 protein interacts with Rb, the question remained
whether expression of Rb was implicated in the anti-apoptotic
function of BAG-1 in tumour cells. Here we show for the first
time that Rb expression is actually required for BAG-1 to
inhibit g-radiation-induced cell death both in Saos-2 osteo-
sarcoma and in colorectal cancer cells. Consistent with the
fact that BAG-1 had previously been shown to promote cell
survival through increasing the activity of the NF-kB family of
transcription factors,23 the ability of BAG-1L to increase
NF-kB activity was significantly inhibited on repression of Rb
expression using an siRNA approach. Taken together, the
data presented suggest a novel function for the Rb, promoting
cell survival through its ability to promote the function of the
BAG-1 protein. As BAG-1 is highly expressed in late-stage
colorectal adenomas and colorectal carcinomas, targeting the
Rb/BAG-1 cellular interaction may provide a selective
mechanism to suppress the pro-survival functions of Rb and
BAG-1 and increase the sensitivity of the colorectal cancer
cells to current therapeutic regimes.
Results
Rb increases nuclear localisation and function of BAG-1
in osteosarcoma-derived Saos-2 cells. As Rb is
expressed in colorectal cancer cells, it was hypothesised
that Rb expression may contribute to tumour cell survival by
regulating the function of the anti-apoptotic BAG-1 protein.
Initial experiments were carried out to establish whether Rb
is implicated in subcellular localisation and hence function of
the BAG-1 protein. For these experiments, we used a model
system to compare BAG-1 localisation and function in the
presence and absence of Rb expression. The Saos-2
osteosarcoma cells (which are Rb null) have been used to
generate an inducible Rb expression system, designated
Saos-2/Rb/DC/R5, which contain a Tet/on inducible RB1-
expression vector38 (kind gift from S Weintraub, Washington,
USA). Induction of Rb expression in the Saos-2 cells lead to
an increase in the nuclear localisation of the endogenous
BAG-1 protein (Figure 1a). To investigate whether this
change in subcellular localisation was due to an interaction
with Rb, BAG-1-binding (Rb-ABC) and non-binding (Rb-C)
Rb fragments (developed and characterised22) were stably
expressed in the Saos-2 cells and the subcellular localisation
of the endogenous BAG-1 protein determined. Nuclear
localisation of the Rb fragments was confirmed by cell
fractionation (Figure 1bii). Expression of the BAG-1-binding
fragment increased the nuclear localisation of endogenous
BAG-1, whereas the non-binding fragment failed to change
the localisation of the BAG-1 protein (Figure 1bi). Taken
together, these data show that expression of Rb increases
the nuclear localisation of BAG-1 protein in Saos-2 cells.
To determine whether Rb expression can regulate the
nuclear activity of BAG-1, we assayed the ability of the Rb
protein to increase BAG-1-dependent NF-kB activation
(implicated in the pro-survival function of BAG-122). In these
experiments, we investigated the effect of Rb expression on
endogenous BAG-1 activity; we knocked down BAG-1 activity
using siRNA in the Saos-2/Rb/DC/R5 cells (±24 h doxycy-
cline (Dox)). These cells were transfected with the NF-kB
reporter construct, stimulated with tumour necrosis factor
a (TNFa) (10 ng/ml) and activation of NF-kB determined after
16 h (Figure 1ci). Interestingly, NF-kB reporter activity was
only significantly increased when endogenous BAG-1 levels
were expressed in the presence of Rb protein (Figure 1ci, lane
4). Therefore, these results suggest that the expression of Rb
in the Saos-2 cells not only increased the nuclear localisation
of BAG-1 but also significantly increased BAG-1 nuclear
function as shown by activation of NF-kB.
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Rb increases nuclear localisation and function of BAG-1
in colorectal cancer cells. As we were interested in Rb
function in colorectal epithelial cells, we next determined
whether expression of Rb was implicated in the predominant
nuclear localisation of total BAG-1 protein in colorectal
tumour cells. An RNAi approach was used to suppress Rb
expression in the SW480 colorectal carcinoma cell line and
confocal imaging to investigate the subcellular localisation of
the BAG-1 protein (Figure 2a). It was found that when Rb
expression was suppressed, there was a shift from the
predominant nuclear localisation of the endogenous BAG-1
protein to a more even distribution of the BAG-1 protein
throughout the cell (Figure 2a – results shown for one Rb
siRNA sequence, parallel results were obtained for a second
sequence, total BAG-1 expression levels did not change
(Figure 2aiiQ1 )). In addition, consistent with previous findings,22
loss of Rb binding through expression of the HPV-E7 protein
also decreased the overall nuclear localisation of endogen-
ous BAG-1 protein in colorectal adenoma-derived cells
(Figure 2b). Further, it is of interest to note that this in vitro
finding models the in vivo localisation of the Rb and BAG-1
proteins in the normal colonic crypt. As shown in Figure 2c,
expression of the Rb nuclear phosphoprotein at the bottom of
the normal crypt (shown by the blue arrow) is coincident with
predominant nuclear localisation of BAG-1 protein (shown by
the red arrow). At the top of the crypt (towards the lumen),
where Rb expression is downregulated,39 the localisation of
the BAG-1 protein is more cytoplamic (shown by the black
arrow). Although correlative, the relative subcellular distribu-
tion of the proteins in vivo supports the in vitro findings that
Rb increases the nuclear localisation of BAG-1.
To study whether Rb expression is also required for the
enhancement of TNFa-induced NF-kB activity by BAG-1 in
colorectal epithelial cells (as shown in Saos-2 cells,
Figure 1 (a) Rb expression increases nuclear localisation of BAG-1 in Saos-2 cells. (ai) Confocal imaging showing Rb and BAG-1 expression in the Saos-2/Rb/DC/R5
±24 h treatment with 1mg/ml Dox. DAPI was used to show nuclear staining. (aii) The induction of Rb expression on treatment with Dox was verified by western blot; a-tubulin
was used as a loading control. (b) Expression of BAG-1 binding, but not the non-binding Rb fragment, increases the nuclear localisation of BAG-1 in Saos-2 cells. (bi) Confocal
imaging of Saos-2 cells stably transfected with the pCDNA3.1 vector only, the Rb-ABC (BAG-1 binding) or the Rb-C (non-binding) fragments, suggesting that the effect of Rb
binding regulates the subcellular localisation of the endogenous BAG-1 protein; DAPI was used to demonstrate nuclear staining. (bii) The nuclear localisation of both Rb
fragments was confirmed by cellular fractionation. PARP was used as a nuclear protein control. (c) BAG-1 can only potentiate NF-kB activity in Saos-2 cells on expression of
Rb protein. (ci) Induction of NF-kB activity, by luciferase reporter assay, stimulated with 10 ng/ml TNFa, for 16 h in Saos-2/Rb/DC/R5 cells. Results are expressed as a
percentage increase over NF-kB activity in the TNFa-treated Rb null Saos-2/Rb/DC/R5 cells, in which endogenous BAG-1 expression has been suppressed using siRNA. The
data represent the mean of three independent experiments±S.D. and statistical differences determined by analysis of variance (ANOVA) with replication, **Po0.01 and
*Po0.05. (cii) Western blot showing Rb expression in the Saos-2/Rb/DC/R5 cell line where the Rb protein is induced by the treatment of 1 mg/ml Dox (lanes 3 and 4), BAG-1
expression showing BAG-1 protein suppression by siRNA (lanes 1 and 3) and endogenous BAG-1 expression in the non-coding negative control (lanes 2 and 4). a-tubulin
expression is shown as control for loading
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Figure 1c), we investigated the level of TNFa-induced NF-kB
activity in SW480 cells, in which BAG-1 and Rb expression
had been repressed (Figure 2d). This approach allowed us to
determine the role of endogenous levels of Rb expression on
the activity of BAG-1 in colorectal tumour cells. For these
experiments, BAG-1 and/or Rb expression was suppressed
by siRNA, cells were transfected with the NF-kB reporter
construct and stimulated with 100 ng/ml TNFa (Figure 2d).
Importantly, when BAG-1 and Rb proteins were expressed
together in the cells, there was a significant increase in NF-kB
activity (Figure 2di, lane 4). These findings suggest that both
BAG-1 and Rb expression are required for increased TNFa-
induced activation of NF-kB in colorectal epithelial cells as
found in the Saos-2 cells.
Rb expression is required for the anti-apoptotic function
of BAG-1L in g-irradiated Saos-2 tumour cells. Pre-
viously, we have reported that BAG-1 inhibited g-radiation-
induced apoptosis in colorectal epithelial cells.34 As Rb was
found to increase the nuclear localisation and function of
Figure 2 (a) Suppression of Rb expression in SW480 cells reduces the nuclear localisation of BAG-1 protein. (ai) Confocal imaging showing Rb and BAG-1 expression in
SW480 cells where Rb expression has been suppressed using siRNA. DAPI was used to demonstrate nuclear staining. The secondary antibody only is shown to control for
nonspecific staining. (aii) Western blot confirming reduction in Rb expression in the siRNA-treated cells. Of note, total BAG-1 levels are not regulated by suppression of Rb
expression. a-tubulin is used as a loading control. (b) HPV-E7 expression decreases the overall nuclear localisation of endogenous BAG-1 protein in colorectal adenoma-
derived cells. Confocal imaging showing Rb and BAG-1 expression in RG/C2 cells expressing either the HPV-E7 protein (RG/C2/RE7) or vector control (RG/C2/Neo). DAPI
used to demonstrate nuclear staining. The secondary antibody only is shown to control for nonspecific staining. (c) Rb and BAG-1 protein expression in the normal colonic
crypt. Tissue sections of normal colonic epithelium stained with the Rb antibody (ci), showing differential staining for Rb. The more intense staining is located at the bottom of
the crypt (blue arrow) and with the TB-3 Bag-1 antibody (cii), showing that the nuclear BAG-1 staining is more intense at the bottom of the crypt (red arrow), and more
cytoplasmic at the top of the crypt (black arrow). (d) Rb expression is required for the enhancement of TNFa-induced NF-kB activity by BAG-1 in SW480 cells. (di) Induction of
NF-kB activity, by luciferase reporter assay, stimulated with 100 ng/ml TNFa, for 16 h in SW480 cells in which BAG-1 and/or Rb expression was suppressed by siRNA. Results
are expressed as a percentage increase over NF-kB activity in the TNFa-treated SW480 cells, in which endogenous BAG-1 and Rb expression has been suppressed using
siRNA. The data represent the mean of three independent experiments ±S.D., statistical differences determined by ANOVA with replication and Tukey’s post-hoc test,
**Po0.01 and ***Po0.001. (dii) Western blot showing Rb and BAG-1 expression in the siRNA-transfected SW480 cells, where Rb expression is suppressed (lanes 1 and 2)
and BAG-1 expression is suppressed (lanes 1 and 3) in both cases, compared with the non-coding negative control. a-tubulin expression is shown as control for loading
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BAG-1 protein (refer to Figure 1), we wanted to investigate
whether expression of Rb in the Saos-2 cells was required for
BAG-1-dependent inhibition of g-radiation-induced apoptosis.
To test this, BAG-1L was expressed in the Saos-2/Rb/DC/R5
(±Dox) cells treated with 10Gy radiation, and apoptosis was
assessed (demonstrated by cleavage of caspase 3 and
PARP, as described in detail previously,40,41 Figure 3aiii).
Interestingly, despite achieving high expression levels
(Figure 3aii), the exclusively nuclear-localised BAG-1L iso-
form was only able to significantly inhibit radiation-induced
apoptosis in the Dox-treated Saos-2/Rb/DC/R5 cells when
Rb is expressed (Figure 3ai, lane 4), consistent with a
requirement for Rb expression for the anti-apoptotic function
of BAG-1L. These data highlight that nuclear localisation of
even high levels of BAG-1 is insufficient to inhibit radiation-
induced apoptosis in the absence of Rb protein expression,
and emphasise that Rb expression is required for the
inhibition of radiation-induced apoptosis by BAG-1 in Saos-2
cells.
Rb expression is required for the anti-apoptotic function
of BAG-1L in colorectal tumour cells. As we are
interested in the regulation of DNA damage-induced apop-
tosis in colorectal tumour cells, it was important to determine
whether Rb expression was also required for the anti-
apoptotic activity of BAG-1 in colorectal epithelial cells.34
To determine the function of Rb, the apoptotic response of
the irradiated SW480 cells was compared with those in which
BAG-1 and Rb expression had been repressed (Figure 4a).
Cells were transfected with BAG-1 and Rb siRNAs or
equivalent non-coding negative control; the induction of
apoptosis 72 h after 5Gy g-irradiation is shown (results
shown for single sequences, parallel results were obtained
for additional sequences, data not shown). Expression of
endogenous levels of BAG-1 in the presence of Rb
(Figure 4ai, lane 4) resulted in a significant reduction of
apoptosis in the irradiated SW480 cells; further highlighting
that BAG-1 and Rb function together to suppress g-radiation-
induced apoptosis in colorectal carcinoma-derived SW480
cells.
To confirm that the interaction between Rb and BAG-1 is
required to protect the cells from radiation-induced apoptosis,
we studied the radiation sensitivity of RG/C2 cells stably
expressing HPV-E7, previously reported to interrupt the Rb/
BAG-1 interaction. Of note, expression of the HPV-E7 protein
did not lead to degradation of Rb protein in these cells
(Figure 4bii), as previously described.22 As HPV-E7 expres-
sion had previously been shown to block the BAG-1L–Rb
complex formation, we were able to address the question
whether nuclear BAG-1 requires interaction with the Rb
protein to repress apoptosis in the cells. Cells were exposed to
5Gy g-radiation, and apoptosis was assessed 72 h after
treatment (Figure 4b). Importantly BAG-1L overexpression
was able to protect the cells against radiation-induced
apoptosis in the control RG/C2/Neo cells (wild-type Rb
function). In contrast, expression of the E7 protein blocked
the anti-apoptotic activity of the BAG-1L protein (Figure 4bi),
supporting the hypothesis that the interaction between Rb and
Figure 3 (a) Overexpression of the nuclear-localised BAG-1L isoform only inhibits radiation-induced apoptosis in Saos-2 cells on expression of Rb protein. (ai) Induction of
apoptosis, in the Saos-2/Rb/DC/R5 cell line, 72 h after exposure to 10 Gy g-irradiation. Cells were stably transfected with the empty Iresneo2 expression vector or Bag-1L, with
or without expression of Rb protein after treatment with 1 mg/ml Dox. The results represent the means of three independent experiments ±S.D., statistical differences
determined by ANOVA with replication and Tukey’s post-hoc test, **Po0.01 and *Po0.05. (aii) Western blot showing Rb expression in the non-induced (lanes 1 and 2) or
Dox-treated (1mg/ml) Saos-2/Rb/DC/R5 (lanes 3 and 4), BAG-1 expression in the cells stably transfected with either the Iresneo2 vector control (lanes 1 and 3) or Bag-1L
(lanes 2 and 4). a-tubulin expression is shown as a loading control. (aiii) Western blot showing cleaved PARP and caspase 3, confirming apoptosis in the irradiated cells.
a-tubulin expression is shown as a loading control. (b) Expression of the GFP-tagged BAG-1L isoform demonstrating nuclear localisation of the protein. Saos-2 cells transiently
transfected with the GFP-tagged Bag-1L, confirming nuclear localisation of the exogenous BAG-1L protein in the absence of Rb expression. Nuclear staining shown by DAPI
Rb increases nuclear localisation and function of BAG-1
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BAG-1 is required for the pro-survival role of BAG-1L in
irradiated cells.
Discussion
Rb acts as a critical co-ordinator in cells, its multiple roles
ensuring cellular and tissue homoeostasis.11 Although a well-
established tumour-suppressor protein, intriguingly Rb
expression is not lost in colorectal carcinogenesis,10,11
suggesting that Rb function is important for colorectal tumour
development. In fact, Rb has been reported to act as a pro-
survival factor in a number of different cell types, hence
retaining Rb expression may be beneficial for other cancers
as well as colorectal cancer, at least until the tumour cells
have acquired other mutations that block the cell-death
pathways.11 However, the mechanism through which Rb
can support tumorigenesis remains to be fully elucidated. In
this context, our previous finding that Rb interacts with the
anti-apoptotic BAG-1 protein was of interest. As BAG-1 has
been reported to be an important survival factor in a number of
different cancers, including colorectal cancer,23,29 we pro-
posed that Rb expression could increase the anti-apoptotic
function of BAG-1. Excitingly, data presented in this study
show that Rb expression is actually required for the anti-
apoptotic function of BAG-1, not only in colon tumour-derived
cell lines but also in the Saos-2 osteosarcoma cell line. This
finding not only highlights a novel role for Rb, promoting the
anti-apoptotic function of the BAG-1 protein in colorectal
tumour cells, but also implies that the Rb–BAG-1 complex
may be important in a wider context, promoting the aberrant
survival of specific tumour cell types where Rb is not acting as
a classical tumour-suppressor gene.
Interestingly, in colorectal cancer cells, it has been reported
that Rb promotes tumour development by preventing the
inhibition of b-catenin transcription by E2F-1.10,12 E2F-1
deregulation has been shown to suppress b-catenin activity
in an adenomatous polyposis coli/glycogen synthase kinase-
3-independent manner, reducing the expression of key
b-catenin targets, including c-MYC. It has been suggested
that this interaction explains why colorectal tumours, which
depend on b-catenin transcription for their abnormal prolifera-
tion, keep RB1 intact.10 In the current paper, we show that Rb
function is also required for the anti-apoptotic function of BAG-
1 and propose that in addition to regulating E2F-1 activity, Rb
may also influence colorectal tumour cell fate through
interaction with BAG-1. This finding is of further significance
for colorectal carcinogenesis in light of a recent report that
BAG-1 expression protects cells from c-MYC-induced apop-
tosis. It was reported that blocking BAG-1 was sufficient to
convert cells from MYC-driven proliferation to MYC-induced
Figure 4 (a) Rb expression is required for the anti-apoptotic function of BAG-1 in irradiated SW480 cells. (ai) Induction of apoptosis in the SW480 cell line 72 h after
exposure to 5 Gy g-irradiation. Cells were transiently transfected with both Rb and Bag-1 siRNA 72 h before being exposed to irradiation. Apoptosis was compared in cells
transfected with Rb, Bag-1 and/or the negative control siRNA. The results represent the means of three independent experiments±S.D., statistical differences determined by
ANOVA with replication and Tukey’s post-hoc test, **Po0.01 and *Po0.05. (aii) Western blot showing Rb and BAG-1 expression in SW480 cells treated with Rb siRNA
(lanes 1 and 2) and/or BAG-1 siRNA (lanes 1 and 3). Controls were transfected with the relevant non-coding negative siRNA. a-tubulin expression was used as a loading
control. (b) The Rb–BAG-1 interaction is required for the anti-apoptotic function of Bag-1 in RG/C2 colorectal adenoma-derived cells. (bi) Induction of apoptosis in the RG/C2/
E7 and RG/C2/Neo cell lines 72 h after exposure to 5 Gy g-irradiation. Cells were stably transfected with Iresneo2 (vector) or expressing Bag-1L. The results represent the
means of three independent experiments±S.D., statistical differences determined by ANOVA with replication and Tukey’s post-hoc test, ***Po0.001. (bii) Western blot
showing Rb and BAG-1 expression in the RG/C2/RE7 cell line and control RG/C2/Neo. Cells stably transfected with either Bag-1L (lanes 2 and 4) or the Iresneo2 vector control
(lanes 1 and 3). a-tubulin expression was used as a loading control. Of note, stable expression of the HPV-E7 protein did not decrease the level of Rb expression in these cells
(as previously reported22)
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apoptosis.37 Therefore, as c-MYC is deregulated early in
colorectal carcinogenesis following b-catenin activation, we
suggest that Rb expression could also be critical for the
inhibition of MYC-induced apoptosis through promoting the
pro-survival activity of BAG-1 in colorectal tumour cells.
Therefore, we would propose that, as well as inhibiting E2F-1
activity (blocking the inhibition of wnt signalling and hence
potentiating b-catenin signalling), Rb may further be required
to promote the anti-apoptotic function of BAG-1 because of
the ensuing deregulated c-MYC activity in colorectal tumour
cells (Figure 5). Hence, it is possible that it is the ability of Rb to
promote the anti-apoptotic function of BAG-1 that is a critical
determinant for retaining Rb expression in tumours with
deregulated c-MYC activity, promoting c-MYC-driven tumor-
igenesis and blocking MYC-induced apoptosis in the early
stages of colorectal carcinogenesis.
Given its key anti-apoptotic role in a number of important
tumours, there has been significant interest in inhibiting the
pro-survival function of BAG-1 in cancer cells. Although
studies investigating the targeting of BAG-1 function ther-
apeutically are in their infancy, a short inhibitory peptide that
blocks association with HSP70 binding, crucial for many of
BAG-1’s pro-survival functions, has been described.42
Furthermore, the same group has identified a small molecule
inhibitor, thioflavin S, which also possesses the capacity to
bind and inhibit the C terminus of BAG-1. Of particular interest
was the fact that both the short peptide and thioflavin S can
inhibit cell growth in a number of high BAG-1-expressing
breast cancer cell lines,43 supporting the premise that
inhibition of BAG-1 function has therapeutic potential in a
number of tumour types. However, results from this study
suggest amore specific way of targeting BAG-1 function in the
cancer cells. As Rb expression was found to be required for
the anti-apoptotic function of BAG-1, disrupting the Rb–BAG-
1 interaction (which is independent of HSP70 binding22) would
be expected to specifically inhibit the pro-survival function of
BAG-1, but not many of the HSP70-dependent activities of
BAG-1, potentially important in normal tissue homoeostasis.
Hence, targeting the Rb–BAG-1 interaction has the potential
to specifically inhibit the anti-apoptotic function of BAG-1 in
tumour cells, and therefore represents a potentially important
novel target for the treatment of colorectal cancer. Further, as
we have demonstrated the Rb–BAG-1 co-operation in
inhibiting apoptosis in the Saos-2 osteosarcoma cell line, as
well as in colorectal tumour cells, we can speculate that such
an approach may have a wider application, increasing the
sensitivity of a number of cancers to current therapeutic
regimes.
Materials and Methods
Cell lines and culture conditions. The human colonic adenoma-derived
S/RG/C2 cell line stably infected with the HPV-E7 oncoprotein (designated RG/C2/
RE7 and corresponding vector control RG/C2/Neo) was maintained on conditioned
medium with neomycin (G418) (Sigma, Poole, UK) at a concentration of 200mg/ml
(previously described34). Both the Rb null Saos-2 osteosarcoma cells (American
Type Culture Collection, MD, USA Q2) and the strain Saos-2/Rb/DC/R5,38 which
contains a Tet/on inducible vector expressing Rb (kind gift from S Weintraub, WA,
USA), are routinely cultured in DMEM (PAA, Yeovil, UK) supplemented with
100 U/ml penicillin (Invitrogen, Paisley, UK), 100mg/ml streptomycin (Invitrogen),
2 mM glutamine (Sigma) and 15% fetal bovine serum (FBS) (PAA). Rb expression
was induced in the Saos-2/Rb/DC/R5 cells by 24-h treatment with 1 mg/ml Dox
(Sigma). The human colonic carcinoma-derived cell line SW480 was obtained from
American Type Culture Collection and cultured in 10% FBS DMEM, as previously
described.
Stable transfections. The parental Saos-2 cell line was transfected using
Genejuice (Novagen, Merck, Nottingham, UK), according to the manufacturer’s
instructions with one of the three plasmids, either a region of Rb that binds BAG-1,
designated Rb-ABC, the non-binding C-fragment, Rb-C or the vector-only control
pCDNA3.1 (Invitrogen). The clones were selected using 400mg/ml G418 (Sigma)
and maintained on 15% FBS DMEM containing 200 mg/ml G418. Verification of
their expression was confirmed by western blotting.
Both the retroviral-infected S/RG/C2 HPV-E7 expressing cells and the
inducible Saos-2/Rb/DC/R5 cells were stably transfected with the nuclear-
localised BAG-1L isoform (gift from G Packham, Southampton, UK) or the
pIRESneo2 vector only (Clontech, CA, USA Q3) using Lipofectamine 2000
(Invitrogen) or Genejuice for the Saos-2/Rb/DC/R5 cells as per the manufacturer’s
instructions. Pooled colonies were maintained on their respective growth medium
containing 200 mg/ml G418. Verification of BAG-1L expression was established by
western blotting.
Confocal imaging. Cells were seeded on 19-mm coverslips, in six-well
plates, and grown for 3 days before being fixed with 4% paraformaldhyde (Sigma)
and Triton-X (Sigma). To induce Rb expression in the inducible Saos-2/Rb/DC/R5,
Dox treatment, 1mg/ml, was applied 24 h before fixture. The cells were dual
stained with the mouse Rb antibody (BD Pharmingen Europe, Erembodegem,
Belgium) and rabbit BAG-1 antibody TB-3 (gift from Graham Packham,
Southampton, UK), both used at a dilution of 1 : 100. Visualisation was achievable
using Alexa 488 (green) anti-mouse (Invitrogen) at a dilution of 1 : 100 and Alexa
546 (red) anti-rabbit at 1 : 200.
siRNA transfection (SW480 and Saos-2/Rb/DC/R5). SW480 cells
were seeded grown to 50% confluent under the standard conditions for 72 h,
before being transfected using Lipofectamine 2000, as per the manufacturer’s
instructions. Suppression of Rb and/or BAG-1 protein was achieved by siRNA
oligonucleotides (Applied Biosystems, TX, USA Q4) at a final dilution of 50 nM siRNA
concentration, controlled with a negative sequence, with no homology to any
sequence in the human genome. A total of 50 nM siRNA was used to achieve
reliable suppression of BAG-1 protein as previously published.23,36 The following
sequences were used: Rb sequence 50-GGUUCAACUACGCGUGUAAtt-30 and
BAG-1 sequence 50-GGGAAAAUCUCUGAAGGAAtt-30. The Saos-2/Rb/DC/R5
cells were transfected with the BAG-1 siRNA using the above method, and Rb
expression was controlled by treatment with 1 mg/ml Dox.
SDS-PAGE – western blotting. Cell samples for western blotting were
prepared by lysing cells for 15 min in lysis buffer (Cell Signaling, MA, USA Q5)
containing Protease Inhibitor Cocktail (Roche, Basel, Switzerland). Cell debris
was removed by centrifugation at 18 500 r.p.m. for 10 min at 4 1C. A Bradford
assay was used to establish the concentration of samples; 100 mg total protein
was diluted in Laemali buffer and loaded per lane using the standard techniques.
Proteins were resolved on a 10% gel and transferred on to Immobilon-P
membrane PVDF (Millipore, MA, USA). Primary antibodies were incubated
overnight; Rb (BD Pharmingen Europe) at 1 : 1000, BAG-1 and G3E2 (gift from
G Packham, Southampton, UK) at 1 : 100 and a-tubulin (Sigma) as a loading
control at a dilution of 1 : 10 000 Q6. All proteins were incubated with horseradish
peroxidase-conjugated goat anti-mouse secondary antibody (Sigma), and bands
were visualised by chemiluminescence (Kirkegaard and Perry Laboratories,
MD, USA Q7).
Figure 5 Schematic of pro-tumorigenic roles of Rb in colorectal cancer (solid
line, from studies;10,12,37 dotted line, regulation of function). Schematic representa-
tion of the proposed dual role for Rb in colorectal tumour cells: as well as inhibiting
E2F-1 activity (blocking the inhibition of wnt signalling and hence increasing
b-catenin activity), Rb is further required to promote the anti-apoptotic function of
BAG-1 in the context of deregulated c-MYC activity in colorectal tumour cells
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Treatment with c-irradiation. Cells were treated at 70% confluence, 24 h
after Dox induction of Rb or 72 h after transient transfection of siRNA. Duplicate
flasks of infected S/RG/C2, SW480 or inducible Saos-2 cells were exposed to
either 5 or 10 Gy, from a 137C source at a dose rate of 0.33 Gy/min, with 20mM
Hepes (Sigma) for buffering. The g-radiation dose used was determined by the
different radiation sensitivity of the cell lines; the dose was adjusted to achieve 25–
30% apoptosis in untransfected cells: S/RG/C2 and SW480 cells were treated with
5 Gy and the Saos-2-derived cells with 10 Gy. Attached and floating cell counts
were determined 72 h after irradiation.
Assessment of apoptosis. The level of apoptosis was determined as
previously described. Cells were confirmed as apoptotic by changes in morphology
as detected by acridine orange staining and cleavage of caspase 3 and PARP, as
described in detail previously.34,40
NF-jB reporter assay (Saos-2/Rb/DC/R5 and SW480). Cells were
transiently transfected with either the NF-kB reporter plasmid pNF-kB-TA-luc or
the control plasmid pTA-luc (Clontech, BD Europe, Erembodegem, Belgium) as
previously described.23 In brief, the Saos-2/Rb/DC/R5 cells were grown to 50%
confluency, under the standard conditions for 72 h, before being co-transfected
with 2.5mg per flask of either reporter constructs and a 50-nM final dilution of
BAG-1 siRNA oligonucleotide or the negative control. After 24 h, the cells were
treated with 1mg/ml Dox, where necessary to induce Rb expression. The SW480
cells were treated with 50 nM Rb and/or BAG-1 siRNA or negative control
oligonucleotides as described above, followed by transfection with the pNF-kB-TA-
luc or control pTA-luc plasmid after 48 h. To stimulate NF-kB activity, cells were
further treated for 16 h with 10 ng/ml TNFa (Saos-2/Rb/DC/R5) or 100 ng/ml TNFa
(SW480).
GFP imaging. Saos-2 parental cells were seeded on 19-mm coverslips, in six-
well plates, and grown for 3 days before being transiently transfected as per the
manufacturer’s instructions, using Genejuice to introduced pEGFP-Bag-1L (gift
from G Packham)34 in the cells. After a further 24 h under normal growth
conditions, the cells were fixed with 4% paraformaldhyde and Triton-X, and
observed under fluorescence.
Immunostaining of normal colonic crypts. Sections were prepared
from archival material retrieved from files at the Department of Histopathology,
Bristol Royal Infirmary, UK, with local Ethic Committee approval. Normal mucosa
was obtained from resection margins at least 6 cm from the tumour mass.
Sections were stained using Rb antibody (BD Pharmingen Europe) at a dilution of
1 : 1000 or BAG-1 antibody, TB-3 (gift from G Packham) used at a dilution of
1 : 1400.
Statistical analysis. Statistical analysis was carried out using SPSS
statistical software for Windows (version 19; SPSS Inc., Chicago, IL, USA).
Analysis of variance was used to determine differences among the means. The
experiments were repeated three times and the results were presented as a mean
of the three separate experiments. Pairwise comparisons were made using
Tukey’s post-hoc test for multiple comparisons.
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